Reduction of Maternal Death Through Postpartum Hemorrhage: A Highly Heat-Resistant Form of Oxytocin that Does Not Require Injection

We will seek to demonstrate measurable levels of the first inhalable formulation of oxytocin in blood and measurable biological effects of inhalation, all this with no seriously adverse side effects. Success will provide the essential platform for the further steps required to move into a first clinical trial. Our ultimate goal is licensure and distribution in affected areas: providing every mother on the planet with access to a life-saving drug when in labor.